论文部分内容阅读
盐酸苯达莫司汀(bendamustine hydrochloride)由美国Cephalon公司研制开发,商品名为Treanda。该药为注射剂,于2008年3月由美国食品药品管理局批准上市,用于治疗慢性淋巴细胞性白血病(chronic lymphocyticleukaemia,CLL)。盐酸苯达莫司汀是一种双功能基烷化剂,其药理作用是通过
Bendamustine hydrochloride (bendamustine hydrochloride) developed by the United States Cephalon company under the trade name Treanda. The drug is an injection and was approved by the U.S. Food and Drug Administration for approval in March 2008 for the treatment of chronic lymphocytic leukemia (CLL). Bendamustine hydrochloride is a bifunctional alkylating agent whose pharmacological action is through